
PRI-724
CAS No. 847591-62-2
PRI-724 ( PRI 724 | PRI724 )
产品货号. M16152 CAS No. 847591-62-2
PRI-724 (PRI724) 是一种有效的、特异性的第二代 CBP/β-catenin 拮抗剂,IC50 为 150 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥405 | 有现货 |
![]() ![]() |
5MG | ¥583 | 有现货 |
![]() ![]() |
10MG | ¥1061 | 有现货 |
![]() ![]() |
25MG | ¥2333 | 有现货 |
![]() ![]() |
50MG | ¥3264 | 有现货 |
![]() ![]() |
100MG | ¥4763 | 有现货 |
![]() ![]() |
500MG | ¥10368 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称PRI-724
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述PRI-724 (PRI724) 是一种有效的、特异性的第二代 CBP/β-catenin 拮抗剂,IC50 为 150 nM。
-
产品描述PRI-724 (PRI724)?is a potent, specific, second generation CBP/beta-catenin antagonist with IC50 of 150 nM, an isomer or enantiomer of ICG-001; binds specifically to the co-activator CBP, but not to p300; selectively induce apoptosis in colon carcinoma cells but not in normal colon cells, and exhibits antitumor activity in the mouse xenograft models of colon cancer.Blood Cancer Phase 2 Clinical.
-
体外实验——
-
体内实验——
-
同义词PRI 724 | PRI724
-
通路Wnt/Notch/Hedgehog
-
靶点Beta-catenin
-
受体Wnt/β-catenin
-
研究领域Cancer
-
适应症Blood cancer
化学信息
-
CAS Number847591-62-2
-
分子量548.63
-
分子式C33H32N4O4
-
纯度>98% (HPLC)
-
溶解度DMSO: 54.9 mg/mL (100 mM);Ethanol: 27.4 mg/mL (50 mM) ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESC1CN([C@H]2CN(C(=O)[C@@H](N2C1=O)CC3=CC=C(C=C3)O)CC4=CC=CC5=CC=CC=C54)C(=O)NCC6=CC=CC=C6
-
化学全称(6S,9aS)-N-benzyl-6-(4-hydroxybenzyl)-8-(naphthalen-1-ylmethyl)-4,7-dioxohexahydro-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Sasaki T, et al. Transl Respir Med. 2014 Sep 11;2:8.
2. Zhang X, et al. Am J Cancer Res. 2015 Jul 15;5(8):2344-60.